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Parenteral injection of tolerated proteins into orally tolerant mice inhibits the initiation of immunological responses to unrelated
proteins and blocks severe chronic inﬂammatory reactions of immunological origin, such as autoimmune reactions. This
inhibitory eﬀect which we have called “indirect eﬀects of oral tolerance” is also known as “bystander suppression.” Herein, we
show that i.p. injection of OVA + Al(OH)3 minutes before i.v. injection of Schistosoma mansoni eggs into OVA tolerant mice
blocked the increase of pulmonary granulomas. In addition, the expression of ICAM-1 in lung parenchyma in areas outside the
granulomas of OVA-orally tolerant mice was signiﬁcantly reduced. However, at day 18 after granuloma induction there was no
diﬀerence in immunoﬂuorescency intensity to CD3, CD4, F4/80, and α-SMA per granuloma area of tolerant and control groups.
ReductionofgranulomasbyreexposuretoorallytoleratedproteinswasnotcorrelatedwithashiftinTh-1/Th-2cytokinesinserum
or lung tissue extract.
1.Introduction
Oral tolerance is a T-cell-mediated phenomenon described
as the inhibition of immune responsiveness to a protein pre-
viously contacted by the oral route [1, 2]. Oral tolerance may
prevent autoimmune and allergic diseases by mechanisms
thatarestillcontroversial[3–5].Twoaspectsoforaltolerance
are of special interest to us because they may reﬂect its broad
and systemic character, suggesting that more insights into
these issues may improve our knowledge of the mechanisms
of oral tolerance. First, oral tolerance is never absolute (com-
plete), that is, parenteral immunization of tolerant animals
with the tolerated antigen may induce antibody formation
at levels inversely proportional to the ingested (tolerizing)
dose of the antigen, but, this antibody formation can no
longer be boostered by further parenteral immunizations
[6]. Second, parenteral reexposure to a tolerated antigen
blocks the initiation of immune responses to a second
unrelated antigen—the eﬀect we have named “indirect eﬀect
of oral tolerance” [7, 8] and is also known as “bystander
suppression” [3, 9]. We have shown that such inhibitory
eﬀect occurs with diﬀerent orally tolerated antigens and even
when the tolerated antigen and the second unrelated antigen
areinjectedintoseparatedsites[7,8].Theinhibitoryindirect
eﬀects of oral tolerance does not require the simultaneous
injection of the tolerated protein and the second antigen: it
is still present 72h after an injection of the tolerated antigen,
butdoesnotoccurifthetoleratedproteinisinjectedafterthe
second antigen [10]. Furthermore, parenteral re-exposure
to a tolerated antigen has systemic eﬀects on the migration
of leucocytes and bone-marrow eosinopoiesis [11], blocks
delayed-type hypersensitivity (DTH) reactions triggered
by keyhole limpet haemocyanin (KLH) and paw oedema
triggered by carragenan [12]. Amazingly, the indirect eﬀects2 Clinical and Developmental Immunology
of oral tolerance to OVA also hinder the inﬂammation after
an incisional skin lesion and improve wound healing in skin
reducing ﬁbrosis [13].
Granulomatous inﬂammation is involved in a num-
ber of diseases, and chronic granulomatous inﬂammation
can cause damage and ﬁbrosis to surrounding tissue [14,
15]. In schistosomiasis mansoni, the chronic egg-induced
granulomatous response in the liver and intestines may
eventually cause extensive tissue scarring and development
of portal hypertension [16]. Immune responses to products
secreted by the eggs (soluble egg antigens, SEA) result in the
formationofgranulomasthatarecomposedofmacrophages,
eosinophils, lymphocytes, and ﬁbroblasts [17]. Similarly
to other inﬂammatory reactions, one critical aspect of
granuloma formation is leukocyte migration dependent on
the expression of adhesion molecules and cytokines [14, 18,
19]. Granulomatous inﬂammation triggered by S. mansoni
eggs and the subsequent ﬁbrosis has been considered a
Th2-cytokine-driven inﬂammation [20]. However, diﬀerent
cytokines including IL-4, TNF-α, IL-10, and IFN-γ are
produced during the course of granuloma formation [21].
Schistosoma mansoni eggs injected into the tail vein of mice
are transported into the lung tissue via the pulmonary arter-
ies where they become trapped within the lung parenchyma
[22, 23]. The injection of S. mansoni eggs into normal
mice allows the study of granulomatous reaction to the eggs
without interference of additional factors triggered by the
presence of the worms and reduces the variability in the size
of granulomas otherwise produced by natural oviposition
[21, 22]. Using the pulmonary granuloma model we have
previously shown that indirect eﬀects of oral tolerance
triggered by i.p. injection of dinitrophenylated conjugates of
OVA (DNP-OVA) emulsiﬁed in complete Freund’s adjuvant
(CFA) inhibit the formation of pulmonary granulomas [24].
To further characterize the indirect eﬀects of oral toler-
ance upon inﬂammatory reactions, we tested if re-exposure
o fO V Ao r a l l yt o l e r a n tm i c et oO V A+A l ( O H ) 3 block
the concomitant formation of pulmonary granuloma. Mice
orally tolerant to OVA and controls not tolerant were i.p.
injected with OVA concomitant with i.v. injection of S.
mansoni live eggs. We compared granulomas size from day
1 to day 18 after i.v. eggs, granuloma cellular composition,
spleen, lung and serum cytokines levels, and the expression
of intercellular adhesion molecule-1 (ICAM-1) in the lung.
2.MaterialsandMethods
2.1. Animals. 8-week-old female C57BL/6 mice were bred
and maintained in the animal breeding unit at the Institute
of Biological Sciences, Universidade Federal de Minas Gerais
(UFMG), Brazil. The animals were fed, housed, and treated
according to the guidelines of the Ethics Committee of Ani-
mal Experimentation (CETEA) of the UFMG. Experimental
groups contained at least ﬁve mice per each time point.
2.2. Feeding Regimens for Oral Tolerance Induction. Oral
tolerance to ovalbumin (OVA) was induced by requiring
mice to drink, ad libitum, a 1:5 solution of chicken egg
white in drinking water for 3 consecutive days. The egg
white solution was prepared in our laboratory from com-
mercially available eggs and contained an average of 4mg
OVA/mL. Daily estimated average consumption was 20mg
OVA/mouse, and this resulted in signiﬁcant levels of tol-
erance [25]. Bottles were changed every day to avoid
contamination. Control groups received ﬁltered tap water.
Oral treatment was discontinued 7 days before granuloma
induction.
2.3. Pulmonary Granuloma. 7 days after oral tolerance
induction, control and experimental animals were injected
i.v. with 2,000 eggs from S. mansoni through a tail vein. Live
S. mansoni eggs were puriﬁed from the livers of S. mansoni
cercariae-infected Swiss mice, which were kindly provided
by Dr. D´ ebora Negr˜ ao Correa, from Universidade Federal de
Minas Gerais, Brasil.
2.4. Parenteral Immunizations. Puriﬁed OVA was obtained
commercially (grade V, Sigma, St. Louis, MO). Mice which
had been pretreated orally with egg white (tolerant group)
and control mice (immune group) received one intraperi-
toneal (i.p.) injection of 0.25mL of a suspension containing
10μg OVA plus 1.6mg Al(OH)3 immediately before the i.v.
egg injection. The other control group (granuloma group)
was not i.p. immunized.
2.5. Bleeding. Blood samples were collected in the absence
of anticoagulant, and serum samples were obtained and
stored at −20◦C until used in a serum antibody assay to test
for tolerance induction or cytometric bead array (CBA) for
quantitative analysis of cytokines.
2.6. Sacriﬁce. Mice were sacriﬁced by cervical dislocation
1, 5, 11, 14, and 18 days after inoculation of S. mansoni
eggs; lungs were collected and ﬁxed for either histology or
immunostaining. In one experiment the spleens were also
collected.
2.7. Histology. For histology lungs were ﬁxed immediately
in Carson’s modiﬁed Millonig’s phosphate buﬀered formalin
(pH = 7,0 for 24h) and embedded in paraﬃn. Serial sections
of 4μm were stained with hematoxylin and eosin (HE)
or Gomori’s trichrome for bright ﬁeld microscopy. Digital
images of tissues were obtained using a BX50 Olympus
microscope (Olympus, Japan) and an Olympus Q Colour 3
Camera, which was connected to a computer running the Q-
Capture Pro software program (Q Imaging, Canada).
2.8. Morphometry. The areas of the granulomas were
measured in a blinded fashion on digitalized photomi-
crographs of HE-stained sections with Image Tool 3.0
software (UTHSCSA, San Antonio, Tex, USA http://ddsdx
.uthscsaedu/dig/itdesc.html).
2.9. Immunostaining and Confocal Microscopy. Immunoﬂu-
orescence labeling and quantitative confocal microscopyClinical and Developmental Immunology 3
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Figure 1:Reductionofgranulomabyre-exposureoforallytolerantanimalstothetoleratedantigen.Serumlevelsof(a)anti-OVAantibodies
and (b) anti-SEA antibodies and (c) pulmonary granuloma area and (d–i) histological aspect of pulmonary granuloma 18 days after i.v.
injection of S. mansoni eggs in nonimmunized mice (granuloma group, open bars), OVA immune controls (hatched bars), and OVA-orally
tolerant (black bars). Normal mice (doted bars) were not immunized with OVA neither injected with eggs. Data represent mean ± SEM.
∗P ≤ 0.05 tolerant versus immune †P ≤ 0.05 immune versus normal. nd: not detected. Original magniﬁcation of HE (d–f) and Gomori’s
trichrome (g–i) photomicrographs 400X; scale bars = 25μm.
were used to investigate the distribution and quantity of
macrophages (F4/80), lymphocytes (CD3+), CD4+ cells,
myoﬁbroblast (α-SMA), and ICAM-1. Brieﬂy, lungs were
immediately ﬁxed and cryosubstituted in a −80◦Cs o l u t i o n
containing80%methanoland20%dimethylsulfoxidefor5–
7 days, transferred to −20◦C for 1-2 days, and then brought
to room temperature as described elsewhere [26]. Samples
were rinsed 3X in absolute ethanol, 2X in xylene and
embedded in paraplast following standard protocols. Five
μm longitudinal sections from the middle of the lung were
dewaxed with xylene and rehydrated through a graded
series of ethanol into PBS. Blocking was achieved using 2%
BSA in PBS at room temperature for 1h followed by an
overnight incubation at 4◦C with primary antibodies diluted
in PBS containing 0.1% BSA and 0.01% Tween-20. The
following antibodies were used: rat anti-F4/80 (eBioscience
San Diego, CA), rat anti-CD3 (Pharmigen, San Diego, CA),
rat anti-CD4 (Pharmigen, San Diego, CA), mouse anti-α-
SMA (Sigma St. Louis, MO) and mouse anti-ICAM-1 (R&D
Systems, San Diego, CA). After 4-5 rinses in PBS, sections
were incubated for 1h at room temperature in the dark with
Alexa 488-conjugated goat antimouse IgG secondary anti-
bodies (Molecular Probes, Eugene, OR) or FITC-conjugated
goat antirat IgG-polyclonal secondary antibody (eBioscience
San Diego, CA). Nuclear counterstainig was made with
4 6-diamidino-2-phenylindol (DAPI). After several rinses in
PBS, sections were mounted in a mixture of 10% 1.0M
Tris-HCl, pH 9.0, and 90% glycerol and analyzed using a
laser scanning confocal microscope (Zeiss 510META; Carl
Zeiss AG, Oberkochen, Germany). Optimal confocal settings4 Clinical and Developmental Immunology
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Figure 2: Granuloma at diﬀerent times after egg injection. Lung HE staining 1, 5, 11, and 14 days after i.v. injection of S. mansoni eggs. (a–c)
At day 1, an inﬂammatory inﬁltrate with predominance of neutrophils and macrophages can be detected around eggs in all groups, but it is
less intense in the tolerant group. (d–f) At day 5, macrophages, eosinophils, and some lymphocytes can be detected. (g–l) At days 11 and 14
granulomas are more organized and some ﬁbroblasts can be detected. Granulomas in tolerant mice follow the same pattern of organization
but do not reach the same size of granulomas in controls group. Scale bars = 25μm.
(aperture,gain,andlaserpower)foreachantibodyusedwere
determined at the beginning of each imaging session and
then held constant during the analysis of all the samples.
The distribution patterns and levels of expression of
F4/80,CD3, CD4, α-SMA,andICAM-1wereanalyzedondi-
gitalized photomicrographs with Image Tool 3.0 software
(UTHSCSA, San Antonio, Tex, USA, http://ddsdx.uthscsa
.edu/dig/itdesc.html). Images were captured at 12 bit and
analyzed in the gray scale range of 0 to 255. Green ﬂuores-
cence intensity was recorded as the sum of gray values of all
pixels divided by the area (in μm2) ×10
−3. Background ﬂu-
orescence was measured in each sample and subtracted from
the values obtained for the ﬂuorescence intensity.
2.10. Spleen Cell Cultures and Cytokine Assay. Spleen cells
were counted and adjusted to concentrations of 1 × 107
cells/mL in RPMI 1640 supplemented with 2% heat inac-
tivated FCS, 2mM L-glutamine (Sigma-Aldrich, Inc.), and
antibiotics (100U/mL penicillin, 100lg/mL streptomycin)
(Sigma-Aldrich, Inc.). Cells were cultured in 96-well ﬂat-
bottom plates at 125μL/well in a humidiﬁed atmosphere
with 5% CO2 with or without soluble schistosome egg
antigens at 50μg/mL culture ﬂuid, ovalbumin at 1mg/mL,
or concanavalin A at 2μg/mL. After 72h, supernatant ﬂuids
were harvested and frozen −20◦C for subsequent cytokine
analysis. The production of IL-10 and IFN-γ by spleen cells
was measured by cytokine capture ELISA.Clinical and Developmental Immunology 5
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Figure 3: Re-exposure of orally tolerant animals to the toler-
ated antigen block enlargement of granuloma area. The area of
granulomas at days 1, 5, 11 and 14 after i.v. injection of eggs in
nonimmunized mice (granuloma group, open bars), OVA immune
controls (hatched bars), and OVA-orally tolerant (black bars). Data
representmean ±SEM(ﬁvemice/group). ∗P ≤ 0.05tolerantversus
immune and †P ≤ 0.05 tolerant versus granuloma.
2.11. Quantitative Analysis of Serum and Lung Cytokines.
Serum samples were collected as previously described and
stored at −20◦C until used. One hundred milligrams of
lung tissue samples from animals of each experimental
groups were homogenized in 1mL of PBS (0.4MNaCl
and 10mM de NaPO4) containing proteases inhibitors
(0.1mM phenylmethylsulfonyl ﬂuoride, 0.1mM benzetho-
nium chloride, 10mM EDTA, and 20KI aprotinin A) and
0.05% Tween 20. The samples were then centrifuged for 10
minutes at 3,000×g and the supernatant immediately used
for quantitative analysis of cytokines. The cytokines (IL-2,
IL-4, IL-5, IFN-γ,a n dT N F - α)i ns e r u ma n dl u n gs a m p l e s
were measured with Cytometric Bead Array (CBA) Mouse
Th1/Th2 kit according to the manufacturer’s speciﬁcations
(BD Biosciences, CA, USA).
2.12. Antibody Assay. Anti-OVA and antisoluble egg antigen
(SEA) antibody titres were determined by standard enzyme-
linked immunosorbent assay (ELISA) using an automatic
ELISA reader (BioRad, Hercules, CA). ELISA scores were
computed by calculating the sums of the optical densities
obtained from the six serum dilutions between 1:50 and
1:1600 of individual mice. The details of the assay method
have been described previously [11, 24, 27]. Each score
shown represents the mean±SEM of the 5 animals in the
group.
StatisticalAnalysiswasperformedusingGraphPadPrism
4 (GraphPad Software, CA, USA), and the statistical signiﬁ-
cance of diﬀerences between groups was determined using
one-way ANOVA followed by Student-Newman-Keuls test.
Values of P ≤ 0.05 were considered signiﬁcant. The results
are expressed as the mean±SEM.
3. Results
3.1. Reexposure of OVA-Orally Tolerant Animals to the Tol-
e r a t e dA n t i g e ni nA l ( O H ) 3 Blocks Granuloma but Not Anti-
SEA Antibody Formation. To induce oral tolerance to OVA
C57BL/6 mice were oﬀered an egg white solution for three
days as their only liquid source (called “tolerant”), and
control mice (called “immune”) drank tap water. Seven days
after interrupting the oral treatment, mice were immunized
i.p. with OVA in Al(OH)3 immediately before the i.v. injec-
tion of live S. mansoni eggs. Another control group (called
“granuloma”) received i.v. injection of eggs without any
otherprevioustreatment.Eighteendaysthereafter,micewere
sacriﬁced and blood and lung were removed for serum anti-
bodies and pulmonary granuloma evaluation. Figure 1(a)
shows that the oral pretreatment with egg white resulted
in tolerance to OVA, that is, anti-OVA antibodies were
signiﬁcantly inhibited as compared with immune mice not
orally pretreated. In contrast, anti-SEA antibodies were aug-
mented in all groups injected with live eggs, irrespective of
other treatments (Figure 1(b)). Noteworthy, granuloma area
was signiﬁcantly smaller in OVA-tolerant mice (Figure 1(c)).
We also performed histological analyses of Gomori’s
trichrome (Figures 1(g)–1(i)) and HE-stained lung sections
(Figures 1(d)–1(f)). Eighteen days after i.v. injection of eggs,
pulmonary granulomas were well organized with concentric
arrangement and composed of macrophages, eosinophils,
lymphocytes and some ﬁbroblasts and epithelioid cells (Fig-
ures 1(d)–1(f)). Granulomas were observed around small
branches of pulmonary arteries. Initial collagen deposition
could be better observed after staining with Gomori’s
trichrome in all groups (Figures 1(g)–1(i)). Inﬂammatory
inﬁltrates in lung parenchyma and alveolar macrophages
were characteristic of all groups, but more prominently
in immune group. Of note, in OVA-tolerant mice the
majority of eggs were surrounded by typical, although
small, granulomas (Figure 1(f)) and their lung parenchyma
presented less inﬂammatory inﬁltrates (not shown).
3.2. Re-Exposure of OVA Orally Tolerant Animals to the Toler-
ated Antigen Blocks Initial Phases of Pulmonary Granuloma
Formation. As described in the literature, the granuloma
formed around S. mansoni eggs has a deﬁned maturational
stage followed by a stage of involution, and, from a
morphological point of view, these stages may be classi-
ﬁed as pregranulomatous and granulomatous stages [28].
The pregranulomatous, exudative stage is characterized by
accumulation of neutrophils, eosinophils, and macrophages
around the egg. The granulomatous stage can be divided
into three phases: exudative-productive, productive, and
involutional. In order to compare the kinetics of granuloma
f o r m a t i o ni nO V At o l e r a n ta n dn o tt o l e r a n tm i c ew e
performed histological analyses of Gomori’s trichrome (not
shown) and HE-stained lung sections. Figure 2 shows HE-
stained sections of the pregranulomatous stage at days 1 and
5afteregginoculation(Figures2(a)–2(f))andgranulomasin
the exudative-productive phase of the granulomatous stage
at days 11 and 14 (Figures 2(g)–2(l)). At day 14, scarce
deposition of collagen ﬁbres could be observed in Gomori’s6 Clinical and Developmental Immunology
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Figure 4: Cell subsets in pulmonary granulomas 18 days after i.v. egg injection. Immunolocalization using speciﬁc antibodies followed by
secondary antibodies coupled with ﬂuorescein (green) and nuclear counterstainig with 4 6-diamidino-2-phenylindol (blue), 18 days after
i.v. eggs injection. Confocal microscope images were captured with a 63X objective, and the graphs represent the green ﬂuorescence intensity
(the sum of gray values of all pixels divided by the area (in μm2) × 10
−3) of expression of F4/80 (macrophages), CD3 (T-lymphocytes),
CD4+ cells, and α-SMA (myoﬁbroblasts) in nonimmunized mice (granuloma group, open bars), OVA immune controls (hatched bars), and
OVA-orally tolerant (black bars). Data represent mean ± SEM of ﬂuorescence intensity of duplicate slides (n = 5 mice/group). The green
autoﬂuorescency of eggs was excluded from all analyses. No signiﬁcant diﬀerence was found between groups.Clinical and Developmental Immunology 7
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Figure 5: Re-exposure of orally tolerant animals to the tol-
erated antigen block the rise of ICAM-1 expression in lung
parenchyma. Immunolocalization of ICAM-1 in granulomas and
lung parenchyma using speciﬁc antibody coupled with ﬂuores-
cein (green) and nuclear counterstainig with 4 6-diamidino-2-
phenylindol (blue), 18 days after i.v. eggs injection. Confocal
microscope images were captured with a 63X objective, and the
graphs represent the green ﬂuorescence intensity (the sum of gray
valuesofallpixelsdividedbythearea(inμm2)×10
−3)ofexpression
of ICAM-1 in the granuloma area (a–d) and in lung parenchyma
(e–h) in nonimmunized mice (granuloma group, open bars), OVA
immune controls (hatched bars), and OVA-orally tolerant mice
(black bars). Data represent mean ± SEM of ﬂuorescence intensity
of duplicate slides (n = 5 mice/group).
trichrome-stained sections (not shown). Granulomas in the
tolerant group followed similar kinetics as that from controls
group, but less intense.
Morphometric analysis (Figure 3) showed that at day 1
the area of granulomas from OVA-tolerant mice is reduced
ascomparedtocontrolmice,butthisdiﬀerencedisappearsat
day 5. However, after day 5, the area of granulomas increased
in controls group and became signiﬁcantly higher than the
area of granulomas in OVA-tolerant mice at days 11 and 14
(Figure 3).
3.3. Re-Exposure of Orally Tolerant Mice to the Tolerated Anti-
gen Do Not Change Granuloma Cell Composition. To further
characterize granuloma cell composition macrophages, T
lymphocytes and myoﬁbroblasts were identiﬁed and quan-
tiﬁed by immunostaining followed by confocal microscopy.
Despite their smaller area, granulomas from tolerant mice
present the same cell subsets as the large granulomas of
controls groups (Figure 4). Even myoﬁbroblasts (α-SMA+)
were present in the smaller granulomas of the Ova orally-
tolerant mice (Figure 4). For technical reasons we could
not perform double immunostaining with anti-CD3 and
anti-CD4 antibodies. To quantify ﬂuorescency, images were
captured at 12bit and analyzed in the gray scale range of 0 to
255. Green ﬂuorescence intensity was recorded as the sum of
gray values of all pixels divided by the area (in μm2)×10
−3 as
described in Section 2. The green auto-ﬂuorescency of eggs
was excluded from all analyses. No signiﬁcant diﬀerence in
ﬂuorescency intensity was found between groups. Then we
can conclude that the reduction in the area of granulomas is
due to proportional reduction of the inﬂammatory cells.
3.4. Re-Exposure of Orally Tolerant Mice to the Tolerated
Antigen Reduces ICAM-1 Expression. Adhesion molecules
enable circulating leukocytes to accumulate in areas of
lung inﬂammation, and adhesion is the initial phase of a
process whereby activated endothelial cells induce leukocyte
migration into tissues. As ICAM-1 has been described as a
predominant adhesion molecule after egg deposition in the
liverofS.mansoniinfectedmice[19]wecompareditsexpres-
sion in lungs after i.v. injection of eggs. Our results show that
the majority of S. mansoni egg-induced ICAM-1 expression
18 days after pulmonary granuloma induction was restricted
to the lung parenchyma outside the granulomas (Figure 5).
The intensity of ICAM-1 expression in the granuloma of
t o l e r a n ta n dc o n t r o l sg r o u pw a sn o td i ﬀerent. However, in
the lung parenchyma outside granulomas, the expression
of ICAM-1 was signiﬁcantly inhibited in the tolerant mice
(Figure 5).
3.5. Reduction of Granulomas by Re-Exposure to Orally
Tolerant Proteins Was Not Correlated with a Shift in Th-
1/Th-2 Cytokines. Using a commercial kit to detect typical
Th1/Th2cytokines,wecomparedthelevelsofIFN-γ,TNF -α,
IL-2, IL-4, and IL-5 in lung homogenates 14 days after
granuloma induction (Figure 6) and in serum samples
(Figure 7) collected 1, 5, 14 and 18 days after granuloma
induction. IFN-γ c o u l db ed e t e c t e di nl u n gh o m o g e n a t e s8 Clinical and Developmental Immunology
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Figure 6: Cytokines production of lungs. Fourteen days after i.v. injection of S. mansoni eggs in nonimmunized mice (granuloma group,
open bars), OVA immune controls (hatched bars), and OVA-orally tolerant mice (black bars), lungs were removed and homogenized in
extract buﬀer. Normal mice (doted bars) were not immunized with OVA and neither injected with eggs. Extract supernatant was collected
for cytokine assay. IFN-γ,T N F - α, IL-2, IL-4, and IL-5 were measured using a Cytometric Bead Array (CBA) kit. The results are shown as
mean concentrations ± SEM. nd: not detected.
(Figure 6)a n ds e r u ma td a y1( Figure 7)i ns o m em i c e
injected with S. mansoni eggs and not in normal (na¨ ıve)
mice, but no diﬀerence was found between the experimental
groups. IL-2 and IL-4 were not detected in serum samples
from any group. IL-2 was detected in the same level in lung
homogenates of normal and experimental groups, and the
l o wl e v e l so fI L - 4d e t e c t e di nl u n gh o m o g e n a t e so fi m m u n e
and tolerant mice did not correlate with the size of their
granulomas. TNF-α was detected in the serum at the same
level in all groups, 14 days after egg injection. At day 1, TNF-
α, and IL-5 were detected in the serum only in the tolerant
group, but not in all mice from this group. In conclusion,
reduction of granulomas in tolerant mice does not correlate
with a shift in Th-1/Th-2 cytokines.
We also compared the production of IFN-γ and IL-10
by spleen cell restimulated “in vitro” with OVA or SEA. TheClinical and Developmental Immunology 9
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Figure 7: Time course of serum cytokines after granuloma
induction. IFN-γ,T N F - α, IL-2, IL-4, and IL-5 were measured using
a Cytometric Bead Array (CBA) kit in serum samples collected
from nonimmunized mice (granuloma group, open bars), OVA
immune controls (hatched bars), and OVA-orally tolerant mice
(black bars). Normal mice (doted bars) were not immunized with
OVA and neither injected with eggs. The results are shown as mean
concentrations ± SEM. nd: not detected. IL-2 and IL-4 were not
detected.
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Figure 8: IFN-γ and IL-10 production of spleen cells stimulated
with SEA or OVA. Eighteen days after i.v. injection of S. mansoni
eggs in nonimmunized mice (granuloma group, open bars), OVA
immune controls (hatched bars), and OVA-orally tolerant mice
(black bars) spleen cells were cultured with medium, ConA, SEA
or OVA for 3 days. Normal mice (doted bars) were not immunized
with OVA neither injected with eggs. The culture supernatant ﬂuids
were harvested and IFN-γ and IL-10 measured by sandwich ELISA.
The results are shown as mean concentrations ± SEM. nd: not
detected.
results in Figure 8 d on o tm a k eu sc o n ﬁ d e n tt oa t t r i b u t e
the reduction of granulomas in tolerant mice to systemic
alteration in the production of these cytokines.
4. Discussion
The standard protocols used to demonstrate tolerance in
orally pre-treated animals involve challenge with the antigen
in adjuvant, and there is evidence that adjuvants play a sig-
niﬁcant role in tolerogenesis during the triggering/parenteral
phase aﬀecting the kind of Ig isotype that is suppressed
or maintained for long periods after oral feeding [29, 30].
Tobagus et al. [30] suggested that when a Th1-selective
adjuvant (such as CFA) is used the resulting response dis-
played selective inhibition of the Th1 component (IFN-γ)
of the immune response while orally pre-treated animals10 Clinical and Developmental Immunology
challenged with the antigen in a Th2-selective adjuvant
(alum) displayed a selective inhibition of Th2 responses.
While oral tolerance is speciﬁc to the antigen contacted by
the oral route, it is noteworthy that the parenteral injection
of small doses (e.g., 10μg) of proteins to which the animal
is orally tolerant triggers a strong inhibition of primary
responses to unrelated antigens [3, 8, 10].
In previous work we have shown that in mice orally-
tolerant to ovalbumin (OVA), anti-SEA and pulmonary
granulomas triggered by i.v. injection of eggs from S.
mansoni were inhibited by i.p. injection of dinitrophenylated
conjugates of OVA (DNP-OVA) emulsiﬁed in complete
Freund’s adjuvant (CFA) [24]. In that work we analysed
granulomas only at day 18 after i.v. egg injection and
found that the more prominent granulomas occurred in
nontolerant mice concomitantly injected with DNP-OVA +
CFA and small granulomas were found in orally tolerant
mice injected with DNP-OVA + CFA. In the tolerant group
eggs were predominant in intravascular locations with initial
periovular reactions containing monocytes, eosinophils, and
collagen ﬁbers derived from the vascular wall [24]. Herein,
we have shown that i.p. injection of OVA plus Al(OH)3 into
OVA-tolerant mice also inhibited pulmonary granuloma but
notanti-SEAantibodiesproduction(Figure 1).Ourprevious
report and the present one as well show that reduction of
granuloma in orally-tolerant mice is independent of the kind
of adjuvant used. On the other hand, inhibition of anti-
SEA antibody formation only occurred when the tolerated
antigens were injected with CFA [24]. Nevertheless, we have
shown that inhibition of antibodies to other proteins such
as KLH and haemoglobin occurs with injection of OVA +
Al(OH)3 in OVA orally-tolerant mice [10, 12]. So, unknown
factors associated with the eggs make it more diﬃcult to
inhibit the anti-SEA antibody response.
This and already published work [3, 9, 11–13] show that
the re-exposure of orally tolerant animals to the tolerated
antigen blocks inﬂammatory reactions. One hallmark of
inﬂammatory processes is the migration of leukocytes to
local areas. Herein we have shown that the injection of
tolerated antigen into orally tolerant mice weakens the inﬂux
of leucocytes into the lung and reduces the size of granuloma
(Figures 1, 2,a n d3). However, the inhibitory eﬀect of oral
tolerance hindered the intensity of migration of cells into
the lung, but not its kinetics, since granulomas followed
the same pattern of formation in tolerant and not tolerant
mice (Figure 2). Furthermore granulomas in tolerant mice
have the same cell composition although in low numbers as
compared to not tolerant mice (Figure 4).
Changes in the expression of cell adhesion molecules ini-
tiate leukocyte traﬃcking, and ICAM-1 is the predominant
adhesion molecule in schistosome egg granuloma formation
[19]. The reduction in the expression of ICAM-1 in tolerant
mice, as shown herein (Figure 5), is certainly involved in the
demonstrated inhibitory eﬀect. We could not ﬁnd signiﬁcant
changes in cytokine secretion, neither in the blood, nor in
lung extracts (Figures 6 and 7). IL-10 was detected after
spleen cell cultures with SEA, but no diﬀerence was found
between tolerant and not tolerant group, and IL-10 concen-
trations in supernatants of spleen cells cultured with OVA
were not diﬀerent from basal production (Figure 8). This
detection may require proper timing, but the present results
argue against major changes in the Th1/Th2 axis.
It is important to pursue these ﬁndings with additional
experiments. Antibody formation may be involved in the
reduction of granulomas in orally-tolerant mice, since B cells
and anti-idyotipic antibodies are involved in the regulation
of granulomas [31, 32] and oral tolerance also aﬀects B
cell and antibody production [29]. In searching for possible
mechanisms involved in inhibitory indirect eﬀects triggered
by parenteral injection of tolerated antigens we must keep in
mind that they aﬀect the initial phases of the inﬂammatory
response which are thought to be primarily innate, as shown
herein and in previous work [13]. This may be taken
as indication that, in addition to speciﬁc immunological
(clonal) events, the exposure to tolerated antigens triggers
other phenomena, for example, of neuroendocrine nature.
5. Conclusion
Parenteral injection of tolerated proteins into orally tolerant
mice blocked the increase of pulmonary granulomas and the
expression of ICAM-1 in lung parenchyma in areas outside
the granulomas. The reduction in the area of granulomas
in tolerant mice is due to proportional reduction of the
inﬂammatory cells and was not correlated with a shift in Th-
1/Th-2 cytokines in serum or lung tissue extract.
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